CAREDX INC. - COMMON STOCK

CareDx Joins Forces with MOTTEP to Increase Organ Donations for Minority Transplant Patients and Support High-Risk, Underserved Communities

20 Jan 2022 06:00:00 By Nasdaq GlobeNewswire

Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance

12 Jan 2022 06:00:00 By Nasdaq GlobeNewswire

CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies

11 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021

10 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection

07 Jan 2022 06:00:00 By Nasdaq GlobeNewswire

CareDx Successfully Completes CLIA Validation of AlloMap Kidney in Preparation for Commercial Launch

06 Jan 2022 06:00:00 By Nasdaq GlobeNewswire

CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy

05 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

CareDx Partners with ISHLT in a Transplant Innovation Research Grant to Improve Outcomes for Heart and Lung Transplant Patients

04 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient Outcomes

16 Dec 2021 06:00:00 By Nasdaq GlobeNewswire

CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study

13 Dec 2021 06:00:01 By Nasdaq GlobeNewswire

CareDx The Transplant Company Surpasses 80,000 Patient Milestone

02 Dec 2021 06:00:00 By Nasdaq GlobeNewswire

CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500™ for the Third Consecutive Year

19 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes

18 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

CareDx To Participate in Upcoming Conferences

15 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence

10 Nov 2021 06:00:03 By Nasdaq GlobeNewswire

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices

04 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

CareDx Focuses on Innovation in Transplant at ASN Kidney Week

03 Nov 2021 06:00:02 By Nasdaq GlobeNewswire

CareDx Completes Orderly Management Transition

01 Nov 2021 15:01:00 By Nasdaq GlobeNewswire

CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance

28 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study

21 Oct 2021 06:00:01 By Nasdaq GlobeNewswire